New developments in the pathogenesis and treatment of steroid-induced osteoporosis

被引:289
作者
Manolagas, SC
Weinstein, RS
机构
[1] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, McClellan VA Med Ctr, Little Rock, AR 72205 USA
关键词
D O I
10.1359/jbmr.1999.14.7.1061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1061 / 1066
页数:6
相关论文
共 39 条
[1]  
ABE E, 1998, BONE, V23, pS242
[2]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[3]  
BELLIDO T, 1998, BONE, V23, pS324
[4]  
BELLIDO T, 1998, BONE, V23, pS518
[5]   Inhibitory actions of glucocorticoids on skeletal growth. Is local insulin-like growth factor I to blame? [J].
Canalis, E .
ENDOCRINOLOGY, 1998, 139 (07) :3041-3042
[6]  
Centrella M, 1997, J CELL BIOCHEM, V67, P528, DOI 10.1002/(SICI)1097-4644(19971215)67:4<528::AID-JCB10>3.0.CO
[7]  
2-5
[8]   Reduction in transforming growth factor β receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid [J].
Chang, DJ ;
Ji, C ;
Kim, KK ;
Casinghino, S ;
McCarthy, TL ;
Centrella, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4892-4896
[9]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137
[10]  
DEMPSTER DW, 1989, J BONE MINER RES, V4, P137